Recent Comments

Comment RSS

Amino Acid News and Research RSS Feed - Amino Acid News and Research

Amino Acid is one of several molecules that join together to form proteins. There are 20 common amino acids found in proteins.

Scientists closer to unraveling the mechanisms of gene regulation

20. November 2009 02:08
A team led by Penn State's Ross Hardison, T. Ming Chu Professor of Biochemistry and Molecular Biology, has taken a large step toward unraveling how regulatory proteins control the production of gene products during development and growth. [More]

Posted in: Medical Science News

Tags: , , , , , , , ,

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

18. November 2009 06:43
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model. [More]

The Center for Modeling Optimal Outcomes discovers causal path of autism

18. November 2009 06:15
During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery. [More]

Posted in: Medical Condition News

Tags: , , , ,

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

17. November 2009 05:02
To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing. [More]

ARCA biopharma provides financial and Gencaro NDA update

17. November 2009 01:01
ARCA biopharma, Inc. today announced its planned next steps in response to the May 29, 2009 Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for ARCA’s New Drug Application (NDA) seeking approval for GencaroTM (bucindolol hydrochloride) for the treatment of patients with chronic heart failure. Following receipt of the CRL, the Company and the FDA have held a series of meetings to discuss how best to address the requirements identified in the CRL. [More]

Scientists to develop a treatment for rare genetic disorder, FOP

13. November 2009 04:10
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton. [More]

Women with high levels of homocysteine more likely to suffer from Alzheimer's disease

6. November 2009 07:42
Middle-aged women with high levels of a specific amino acid in their blood are twice as likely to suffer from Alzheimer's many years later, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden. This discovery this could lead to a new and simple way of determining who is at risk long before there are any signs of the illness. [More]

Posted in: Medical Condition News | Women's Health News

Tags: , , , ,

Patent covering the approved administration of Kuvan with food for the treatment of PKU issued

6. November 2009 02:24
BioMarin Pharmaceutical Inc. announced today that the United States Patent and Trademark Office has issued a patent covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food for the treatment of phenylketonuria (PKU). The patent expires in 2024. [More]

Posted in: Medical Patent News | Pharmaceutical News

Tags: , , , ,

Shire receives FDA Priority Review for velaglucerase alfa NDA

4. November 2009 07:58
Shire plc, the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for velaglucerase alfa, the company's enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease. [More]

Study: Gene therapy can reduce symptoms of Huntington's disease

31. October 2009 01:48
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models. [More]

Scientists present new perspective on antigenic drift of flu viruses

30. October 2009 07:28
Influenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein. This shape-shifting, called antigenic drift, is why influenza vaccines-which are designed to elicit antibodies matched to each year's circulating virus strains-must be reformulated annually. [More]

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

28. October 2009 05:34
NCKU President, Academician Michael Ming-Chiao Lai, signed Technology Transfer Agreement in this morning with Mr. Tou-Hsiung Yang, Chairman of Vedan International (Holding) Ltd, witnessed by Vedan Biotechnology President Shih-An (Raymond) Yang and the inventor, Prof. Huey-Lang Yang of the NCKU Institute of Biotechnology. [More]

Ohio State University researchers first to observe real-time behavior of the Dpo4 enzyme

28. October 2009 04:34
Scientists here have identified how the motions of an enzyme are related to correctly copying genetic instructions, setting the stage for studies that can uncover what happens when DNA copying mistakes are made. [More]

Posted in: Medical Science News

Tags: , , , , , ,

Amorfix Life Sciences signs sale and distribution agreement with Cedarlane Laboratories

22. October 2009 07:46
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, announced today that it has signed an agreement with Cedarlane Laboratories for the sale and distribution of Amorfix's proprietary antibodies and reagents. [More]

Posted in: Business / Finance | Pharmaceutical News

Tags: , , , ,

Rice University scientists win NIH stimulus funds to study influenza A

21. October 2009 00:17
Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.